Clinical Trial Update: Cost Effectiveness of Glargine Insulin Versus NPH Insulin [Phase 4]

View source ↗

Summary

This Phase 4 study assesses the cost-effectiveness of branded insulin glargine compared with NPH insulin in Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED